Results 281 to 290 of about 3,996,783 (390)

Risk predictive tools of perioperative drug hypersensitivity reaction: A case-control study. [PDF]

PLoS One, 2022
Pradhan U, Oofuvong M, Karnjanawanichkul O, Pakpirom J.   +3 more
europepmc   +1 more source

Multicenter study of continuing ustekinumab after intravenous induction reactions in pediatric Crohn's disease

JPGN Reports, EarlyView.
ABSTRACT Reactions to intravenous ustekinumab for inflammatory bowel disease (IBD) occur, the frequency of which is uncertain. It is unclear how often subcutaneous treatment is continued after reactions to the intravenous dose, or how well it is tolerated.
Joann Samalik, Andrew Singer, Sabina Ali, Archana Anandakrishnan, Michaella K. Baker, Jana Creps, Camila Khorrami, Ross M. Maltz, Lauren Manning, Jonathan Moses, Brad Pasternak, Perseus V. Patel, Dianne C. Singer, David L. Suskind, Becca Trombler, Jeremy Adler, for the ImproveCareNow Pediatric IBD Learning Health System   +16 more
wiley   +1 more source

Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia. [PDF]

Allergol Select
Townsend K, Leck C, Billahalli T, Barachina E, Watts TJ.   +4 more
europepmc   +1 more source

Drug Hypersensitivity Syndrome Induced by Meglumine Antimoniate [PDF]

, 2009
Fakhri Jeddi, Éric Caumes, Marc Théllier, Stéphane Jauréguiberry, Dominique Mazier, Pierre Buffet   +5 more
openalex   +1 more source

Bee products as alternatives in the treatment of viral infections

Journal of the Science of Food and Agriculture, EarlyView.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba, Łukasz Marek, Jerzy Stojko, Anna Rzepecka‐Stojko   +3 more
wiley   +1 more source

Association of Tralokinumab and Adalimumab: Good Tolerance and Efficacy in a Case of Severe Atopic Dermatitis and Juvenile Idiopathic Arthritis

JEADV Clinical Practice, EarlyView.
ABSTRACT Atopic dermatitis is a chronic inflammatory and pruritic skin disease. The combination of tralokinumab with adalimumab in the treatment of inflammatory diseases had not yet been documented. It appears promising for treating severe atopic dermatitis in patients with juvenile idiopathic arthritis, offering significant improvement in skin ...
F. Rakotonandrasana, E. Puzenat, A. Ducournau, D. Popescu   +3 more
wiley   +1 more source

Knowledge mapping and global trends of drug hypersensitivity from 2013 to 2023: A bibliometric analysis. [PDF]

Immun Inflamm Dis
Luo L, Chen N, Li Z, Zhao C, Dong Y, Wang L, Li X, Zhou W, Li Y, Gao C, Guo X.   +10 more
europepmc   +1 more source

Strategy to Prevent Drug-Related Hypersensitivity in Folate-Targeted Hapten Immunotherapy of Cancer [PDF]

, 2009
Yingjuan Lu, Patrick Klein, Elaine Westrick, Le-Cun Xu, Hari Krishna R. Santhapuram, Alicia Bloomfield, Stephen Howard, Iontcho R. Vlahov, P. R. Ellis, Philip S. Low, Christopher P. Leamon   +10 more
openalex   +1 more source

Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group

Allergy. European Journal of Allergy and Clinical Immunology, 2016
E. Gomes, K. Brockow, S. Kuyucu, F. Saretta, F. Mori, N. Blanca‐Lopez, Hagen Ott, M. Atanasković-Marković, M. Kidon, J. Caubet, I. Terreehorst   +10 more
semanticscholar   +1 more source

Perioperative Management Conundrum for a Case With Multiple Commonly Used Drug Hypersensitivity. [PDF]

Cureus
Bansal V, Karim HMR, Rai AK, Bhuyan D, Kumar S.   +4 more
europepmc   +1 more source